- Home
- LTRN vs ACXP Comparison
LTRN vs ACXP Comparison
Compare LTRN & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- ACXP
- Stock Information
- Founded
- LTRN 2013
- ACXP 2017
- Country
- LTRN United States
- ACXP United States
- Employees
- LTRN N/A
- ACXP N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- LTRN Health Care
- ACXP Health Care
- Exchange
- LTRN Nasdaq
- ACXP Nasdaq
- Market Cap
- LTRN 36.0M
- ACXP 8.4M
- IPO Year
- LTRN 2020
- ACXP 2021
- Fundamental
- Price
- LTRN $4.02
- ACXP $0.45
- Analyst Decision
- LTRN Strong Buy
- ACXP Strong Buy
- Analyst Count
- LTRN 1
- ACXP 2
- Target Price
- LTRN $25.00
- ACXP $10.00
- AVG Volume (30 Days)
- LTRN 312.5K
- ACXP 1.1M
- Earning Date
- LTRN 08-07-2025
- ACXP 08-08-2025
- Dividend Yield
- LTRN N/A
- ACXP N/A
- EPS Growth
- LTRN N/A
- ACXP N/A
- EPS
- LTRN N/A
- ACXP N/A
- Revenue
- LTRN N/A
- ACXP N/A
- Revenue This Year
- LTRN N/A
- ACXP N/A
- Revenue Next Year
- LTRN N/A
- ACXP N/A
- P/E Ratio
- LTRN N/A
- ACXP N/A
- Revenue Growth
- LTRN N/A
- ACXP N/A
- 52 Week Low
- LTRN $2.55
- ACXP $0.30
- 52 Week High
- LTRN $6.12
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- LTRN 67.20
- ACXP 48.12
- Support Level
- LTRN $3.15
- ACXP $0.40
- Resistance Level
- LTRN $4.43
- ACXP $0.46
- Average True Range (ATR)
- LTRN 0.38
- ACXP 0.06
- MACD
- LTRN 0.11
- ACXP -0.01
- Stochastic Oscillator
- LTRN 80.91
- ACXP 26.88
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.